Conceptual illustrationTreatments
Treatment pathways and therapy methods
Explore how regenerative medicine, stem cell therapy, mesenchymal stromal cells, organ-specific cell approaches and clinical research differ — and what must be verified before an international patient travels.
Condition-specific pathways
Start with a diagnosis, not a generic injection.
The same cell product should not be assumed to treat unrelated diseases. A credible pathway connects a defined condition, a specific product or procedure, a qualified institution and a reviewable eligibility process.
Conceptual illustration
Conceptual illustration
Conceptual illustrationMethods explained
Different methods require different questions.
A broad label such as “stem cells” does not tell you the source, identity, manufacturing quality, delivery route, indication, evidence or legal pathway.
Method 01
Stem cell therapy in China
A patient guide to terminology, evidence, access routes and red flags.
Learn more →Method 02Cell therapy in China
Understand autologous, donor-derived and organ-specific cell approaches.
Learn more →Method 03Mesenchymal stromal cells
Why source, dose, manufacturing, indication and evidence cannot be treated as interchangeable.
Learn more →Method 04Clinical trial matching
How registered research differs from a paid clinical application.
Learn more →Method 05Treatment-offer verification
Independent review of a proposal received from another provider.
Learn more →Method 06Healthy aging programmes
Assessment-led longevity care, separate from unsupported cell-treatment claims.
Learn more →
Technology is only one part of access.The institution, regulatory pathway, indication and patient-specific eligibility matter equally.
How we classify a pathway
One treatment label can hide very different realities.
When we review a pathway, we look for the exact product or procedure, the condition being treated, the regulatory and clinical status, the treating institution, the current intake route and the information required from the patient.
- What is the exact cell or biologic product?
- Is it patient-derived or donor-derived?
- What condition and disease stage is it intended for?
- Is it a clinical application, a drug trial or another research pathway?
- Does the institution currently accept foreign patients?
- What benefits, risks and uncertainties are disclosed?
Common questions
Before choosing a therapy method
Regenerative medicine is a broad field that includes cell therapies, tissue engineering, biologic products and strategies intended to repair or restore function. Stem cell therapy is one possible category within that field.
A pathway may be publicly reported in China while current foreign-patient intake, passport requirements, eligibility and formal pricing still need direct confirmation from the treating institution.
The website helps you understand options, but it is not an online shop. Treatment selection follows diagnosis review, specialist assessment, informed consent and a formal institutional plan.
We explain registered clinical trials separately from clinical applications. Trial participation is governed by the protocol and must not be sold as a commercial treatment package.
Medical assessment
Start with a confidential case summary
Tell us your diagnosis, current treatment and main goal. We will first check whether a credible pathway may justify formal hospital review.